4//SEC Filing
Graham Neil 4
Accession 0001694665-20-000026
CIK 0001694665other
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 4:43 PM ET
Size
5.3 KB
Accession
0001694665-20-000026
Insider Transaction Report
Form 4
Graham Neil
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-04-08+150,000→ 150,000 totalExercise: $3.72Exp: 2030-04-08→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]These options will vest as to 25% of the total grant on April 6, 2021 with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to continued employment on such dates.
Documents
Issuer
Evelo Biosciences, Inc.
CIK 0001694665
Entity typeother
Related Parties
1- filerCIK 0001330408
Filing Metadata
- Form type
- 4
- Filed
- Apr 9, 8:00 PM ET
- Accepted
- Apr 10, 4:43 PM ET
- Size
- 5.3 KB